(Q46456550)

22 December 2017

title

Plasminogen activator inhibitor-1 removal using dextran sulphate columns. Evidence of PAI-1 homeostasis (English)

1 reference

22 December 2017

author name string

Vincent M G Maher

1

1 reference

22 December 2017

Yuri Kitano

2

1 reference

22 December 2017

Clare Neuwirth

3

1 reference

22 December 2017

Graham J Davies

4

1 reference

22 December 2017

Attilio Maseri

5

1 reference

22 December 2017

Gilbert R Thompson

6

1 reference

22 December 2017

Felicita Andreotti

7

1 reference

22 December 2017

publication date

30 July 2008

1 reference

22 December 2017

Journal of Thrombosis and Thrombolysis

published in

1 reference

22 December 2017

volume

28

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

166-172

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s11239-008-0260-8

exact match

0 references

cites work

Unsaturated Fatty Acids Increase Plasminogen Activator Inhibitor-1 Expression in Endothelial Cells

2 references

Crossref

https://api.crossref.org/works/10.1007%2FS11239-008-0260-8

21 January 2018

12 December 2020

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

12 December 2020

Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis

1 reference

12 December 2020

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

1 reference

12 December 2020

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

1 reference

12 December 2020

Hemostatic variables in homozygous familial hypercholesterolemia. Effect of regular plasma cholesterol removal by low density lipoprotein apheresis

1 reference

12 December 2020

Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes.

1 reference

12 December 2020

Dietary regulation of fibrinolytic factors

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogram

1 reference

12 December 2020

Identification of and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1

1 reference

12 December 2020

The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with streptokinase

1 reference

12 December 2020

Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction

1 reference

12 December 2020

Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease

1 reference

12 December 2020

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

12 December 2020

S35225 is a direct inhibitor of Plasminogen Activator Inhibitor type-1 activity in the blood

1 reference

12 December 2020

Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis

1 reference

12 December 2020

4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke

1 reference

12 December 2020

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

1 reference

12 December 2020

Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population.

1 reference

12 December 2020

Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects.

1 reference

12 December 2020

Plasminogen activator inhibitors

1 reference

12 December 2020

A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis)

1 reference

12 December 2020

Overweight/obesity, smoking, and heavy alcohol consumption are important determinants of plasma PAI-1 levels in healthy men.

1 reference

12 December 2020

Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells.

1 reference

12 December 2020

Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue

1 reference

12 December 2020

Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.

1 reference

12 December 2020

Effect of propranolol (long-acting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1

1 reference

12 December 2020

Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.

1 reference

12 December 2020

10.1007/S11239-008-0260-8

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017